Anbio Biotechnology Class A Ordinary Shares (NNNN) Revenue & Revenue Breakdown
Anbio Biotechnology Class A Ordinary Shares Revenue Highlights
Latest Revenue (Y)
$8.19M
Latest Revenue (Q)
$2.53M
Anbio Biotechnology Class A Ordinary Shares Revenue by Period
Anbio Biotechnology Class A Ordinary Shares Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $8.19M | 21.95% |
2023-12-31 | $6.71M | -71.49% |
2022-12-31 | $23.54M | 431.67% |
2021-12-31 | $4.43M | - |
Anbio Biotechnology Class A Ordinary Shares generated $8.19M in revenue during NA 2024, up 21.95% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Anbio Biotechnology Class A Ordinary Shares Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-12-31 | $2.53M | -60.01% |
2024-06-30 | $6.32M | 60.04% |
2023-12-31 | $3.95M | 19.49% |
2023-06-30 | $3.31M | - |
Anbio Biotechnology Class A Ordinary Shares generated $2.53M in revenue during Q4 2024, up -60.01% compared to the previous quarter, and up 0.00% compared to the same period a year ago.